Logo image of RFL

RAFAEL HOLDINGS INC-CLASS B (RFL) Stock Fundamental Analysis

NYSE:RFL - US75062E1064 - Common Stock

1.45 USD
-0.07 (-4.61%)
Last: 9/4/2025, 4:10:02 PM
Fundamental Rating

2

Overall RFL gets a fundamental rating of 2 out of 10. We evaluated RFL against 195 industry peers in the Pharmaceuticals industry. While RFL seems to be doing ok healthwise, there are quite some concerns on its profitability. RFL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year RFL has reported negative net income.
RFL had a negative operating cash flow in the past year.
RFL had negative earnings in each of the past 5 years.
RFL had a negative operating cash flow in each of the past 5 years.
RFL Yearly Net Income VS EBIT VS OCF VS FCFRFL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -21.18%, RFL is in line with its industry, outperforming 59.49% of the companies in the same industry.
With a decent Return On Equity value of -28.41%, RFL is doing good in the industry, outperforming 60.51% of the companies in the same industry.
Industry RankSector Rank
ROA -21.18%
ROE -28.41%
ROIC N/A
ROA(3y)-47.6%
ROA(5y)-33.28%
ROE(3y)-55.93%
ROE(5y)-39.35%
ROIC(3y)N/A
ROIC(5y)N/A
RFL Yearly ROA, ROE, ROICRFL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

RFL has a better Gross Margin (74.86%) than 83.08% of its industry peers.
The Profit Margin and Operating Margin are not available for RFL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RFL Yearly Profit, Operating, Gross MarginsRFL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

More info and screens

4

2. Health

2.1 Basic Checks

RFL does not have a ROIC to compare to the WACC, probably because it is not profitable.
RFL has more shares outstanding than it did 1 year ago.
RFL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, RFL has a worse debt to assets ratio.
RFL Yearly Shares OutstandingRFL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
RFL Yearly Total Debt VS Total AssetsRFL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -1.86, we must say that RFL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.86, RFL is in line with its industry, outperforming 46.67% of the companies in the same industry.
RFL has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.01, RFL is in line with its industry, outperforming 59.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -1.86
ROIC/WACCN/A
WACC10.04%
RFL Yearly LT Debt VS Equity VS FCFRFL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

RFL has a Current Ratio of 3.85. This indicates that RFL is financially healthy and has no problem in meeting its short term obligations.
RFL has a better Current ratio (3.85) than 63.08% of its industry peers.
RFL has a Quick Ratio of 3.82. This indicates that RFL is financially healthy and has no problem in meeting its short term obligations.
RFL has a better Quick ratio (3.82) than 64.62% of its industry peers.
Industry RankSector Rank
Current Ratio 3.85
Quick Ratio 3.82
RFL Yearly Current Assets VS Current LiabilitesRFL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.01% over the past year.
The Revenue has grown by 35.06% in the past year. This is a very strong growth!
The Revenue for RFL have been decreasing by -33.59% on average. This is quite bad
EPS 1Y (TTM)21.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.96%
Revenue 1Y (TTM)35.06%
Revenue growth 3Y-7.31%
Revenue growth 5Y-33.59%
Sales Q2Q%7.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RFL Yearly Revenue VS EstimatesRFL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RFL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RFL Price Earnings VS Forward Price EarningsRFL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RFL Per share dataRFL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RFL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RAFAEL HOLDINGS INC-CLASS B

NYSE:RFL (9/4/2025, 4:10:02 PM)

1.45

-0.07 (-4.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)06-17 2025-06-17
Earnings (Next)11-04 2025-11-04
Inst Owners7.7%
Inst Owner Change16.7%
Ins Owners45.18%
Ins Owner Change3.62%
Market Cap50.88M
Analysts0
Price TargetN/A
Short Float %0.41%
Short Ratio0.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 69.51
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB 2.58
EV/EBITDA N/A
EPS(TTM)-0.94
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0.02
BVpS2.3
TBVpS0.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.18%
ROE -28.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.86%
FCFM N/A
ROA(3y)-47.6%
ROA(5y)-33.28%
ROE(3y)-55.93%
ROE(5y)-39.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.88%
Cap/Sales 7.1%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.85
Quick Ratio 3.82
Altman-Z -1.86
F-Score4
WACC10.04%
ROIC/WACCN/A
Cap/Depr(3y)26.37%
Cap/Depr(5y)24.37%
Cap/Sales(3y)9.31%
Cap/Sales(5y)13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.06%
Revenue growth 3Y-7.31%
Revenue growth 5Y-33.59%
Sales Q2Q%7.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y83.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.86%
OCF growth 3YN/A
OCF growth 5YN/A